The unique guinea pig hybridoma technology is adopted to generate monoclonal guinea pig antibodies. Through fusing with our specific myeloma as partner, guinea pig hybridoma can be developed with excellent stability and productivity. https://www.creative-biolabs.com/blog/index.php/creative-biolabs-makes-breakthrough-in-guinea-pig-monoclonal-antibody-production-with-hybridoma-technology/.